Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)

November 2006

Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).

About 5% of reproductive age women have this more severe form of premenstrual syndrome.

Yaz contains the same ingredients as Yasmin, but with less estrogen per pill. Also, Yaz has four days of placebo a pack...Yasmin has seven.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote